-+ 0.00%
-+ 0.00%
-+ 0.00%

Jefferies Maintains Buy on Verastem, Raises Price Target to $13

Benzinga·10/15/2026 16:33:18
语音播报
Jefferies analyst Faisal Khurshid maintains Verastem (NASDAQ:VSTM) with a Buy and raises the price target from $11 to $13.